Nivolumab vs Ramipril

## Nivolumab vs Ramipril: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Ramipril**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Ramipril**: Prodrug converted to ramiprilat; ACE inhibitor.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Ramipril — 13-17 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Ramipril — C23H32N2O5.

**Molecular Weight**: Nivolumab — N/A; Ramipril — 416.5120 g/mol.

**Type**: Nivolumab — Antibody; Ramipril — Small molecule.